These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 22466318

  • 21. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC, Raff H, Findling JW.
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [Abstract] [Full Text] [Related]

  • 22. The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome.
    Reimondo G, Paccotti P, Minetto M, Termine A, Stura G, Bergui M, Angeli A, Terzolo M.
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):718-24. PubMed ID: 12780748
    [Abstract] [Full Text] [Related]

  • 23. Low Diagnostic Utility of Overnight High-Dose Dexamethasone Suppression Test in ACTH-Dependent Cushing's Syndrome.
    Kumar A, Kanwar J, Bharti N, Agrawal V, Bhatia E, Yadav SC.
    Endocr Pract; 2021 Jul; 27(7):723-727. PubMed ID: 34250909
    [Abstract] [Full Text] [Related]

  • 24. First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS.
    Ceccato F, Antonelli G, Frigo AC, Regazzo D, Plebani M, Boscaro M, Scaroni C.
    J Endocrinol Invest; 2017 Jul; 40(7):753-760. PubMed ID: 28247215
    [Abstract] [Full Text] [Related]

  • 25. Screening for Cushing's syndrome in obese patients.
    Tiryakioglu O, Ugurlu S, Yalin S, Yirmibescik S, Caglar E, Yetkin DO, Kadioglu P.
    Clinics (Sao Paulo); 2010 Jul; 65(1):9-13. PubMed ID: 20126340
    [Abstract] [Full Text] [Related]

  • 26. [Comparison of efficacy between the serum cortisol and 24 hour urine free cortisol in combined dexamethasone suppression test in the diagnosis of Cushing syndrome].
    Lu L, Chen JH, Zhu HJ, Song AL, Li M, Chen S, Pan H, Gong FY, Wang RZ, Xing B, Yao Y, Feng M, Lu ZL.
    Zhonghua Yi Xue Za Zhi; 2016 Jul 19; 96(27):2150-4. PubMed ID: 27464539
    [Abstract] [Full Text] [Related]

  • 27. Overnight urinary free cortisol determination: a screening test for the diagnosis of Cushing's syndrome.
    Corcuff JB, Tabarin A, Rashedi M, Duclos M, Roger P, Ducassou D.
    Clin Endocrinol (Oxf); 1998 Apr 19; 48(4):503-8. PubMed ID: 9640418
    [Abstract] [Full Text] [Related]

  • 28. Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild cushing's disease from pseudo-Cushing's syndrome.
    Gatta B, Chabre O, Cortet C, Martinie M, Corcuff JB, Roger P, Tabarin A.
    J Clin Endocrinol Metab; 2007 Nov 19; 92(11):4290-3. PubMed ID: 17635947
    [Abstract] [Full Text] [Related]

  • 29. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM, Grossman AB.
    J Clin Endocrinol Metab; 2003 Nov 19; 88(11):5299-306. PubMed ID: 14602765
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome.
    Putignano P, Toja P, Dubini A, Pecori Giraldi F, Corsello SM, Cavagnini F.
    J Clin Endocrinol Metab; 2003 Sep 19; 88(9):4153-7. PubMed ID: 12970280
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [The value of corticotropin-releasing hormone (CRH) test for differential diagnosis of Cushing's syndrome].
    Penezić Z, Zarković M, Vujović S, Ivović M, Beleslin B, Ciric J, Drezgić M.
    Srp Arh Celok Lek; 2007 Sep 19; 135(1-2):31-7. PubMed ID: 17503565
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Cushing's syndrome: diagnostic exploration].
    Tabarin A, Roger P.
    Presse Med; 2007 Sep 19; 23(1):43-8. PubMed ID: 8127815
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The 4-mg intravenous dexamethasone suppression test in the diagnosis of Cushing's syndrome.
    Jung C, Alford FP, Topliss DJ, Burgess JR, Long F, Gome JJ, Stockigt JR, Inder WJ.
    Clin Endocrinol (Oxf); 2010 Jul 19; 73(1):78-84. PubMed ID: 20039897
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.